Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FYX16
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $487,499
Award facts
- Contract value 100% obligated
- $487,498.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On July 18, 2025, the Defense Logistics Agency awarded a delivery order valued at $487,498.50 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order is expected to be completed by August 8, 2025, with performance taking place at the vendor's Park Ridge facility. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete directly in the open federal market despite its small business status.
This delivery order is issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.99 billion vehicle valid through November 2026 that enables the issuance of firm fixed-price delivery orders for pharmaceutical products supporting military health facilities worldwide. As a primary supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group has consistently delivered an extensive portfolio of branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites. The Stelara delivery represents a continuation of the company's role as a critical distributor of specialized pharmaceutical products to military medical facilities across the nation.
Quick answers
Who was awarded contract SPE2DB25FYX16?
SPE2DB25FYX16 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 18, 2025.
How much is contract SPE2DB25FYX16 worth?
The government has obligated $487,499 on SPE2DB25FYX16.
Is contract SPE2DB25FYX16 an order under another contract?
Yes. SPE2DB25FYX16 is a delivery order under SPE2DB22D9133, an indefinite delivery contract.
Was contract SPE2DB25FYX16 competed?
The extent of competition for SPE2DB25FYX16 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award